ACET Adicet Bio, Inc.
Nasdaq · SEC CIK 1720580 · EDGAR
- Bought, last 12 months
- $6.60M 2 purchases by 2 insiders
- Sold, last 12 months
- $674.8K 1 sales by 1 insiders
- Filings on record
- 157 since 2021-10-05, latest 2026-08-07 16:01
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% | $5.00M | $674.8K |
| RA CAPITAL MANAGEMENT, L.P. | 10% | $1.60M | — |
| Aftab Blake | CSO | — | — |
| Healey Don | CTO | — | — |
| Harvey Brian Nicholas | CFO | — | — |
| Schor Chen | Pres, CEO, Dir | — | — |
Transactions 127
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-04-29 16:15 | 2026-04-27 | ACET | RA CAPITAL MANAGEMENT, L.P. | 10% | J - Other | — | -250.0K | 932.6K | -21% | — |
| MI | 2026-04-13 17:20 | 2026-02-18+ | ACET | RA CAPITAL MANAGEMENT, L.P. | 10% | P - Purchase | $7.17 | +223.6K | 1.18M | +23% | +$1.60M |
| MI | 2026-04-09 17:38 | 2026-04-07+ | ACET | ORBIMED ADVISORS LLC | 10% | S - Sale | $6.45 | -104.7K | 0 | -100% | -$674.8K |
| 2026-01-27 | 2026-01-24 | ACET | Healey Don | CTO | F - Tax | $8.44 | -535 | 3,452 | -13% | -$4,515 | |
| 2026-01-27 | 2026-01-24 | ACET | Aftab Blake | CSO | F - Tax | $8.44 | -535 | 2,981 | -15% | -$4,515 | |
| 2026-01-27 | 2026-01-24 | ACET | Harvey Brian Nicholas | CFO | F - Tax | $8.44 | -546 | 5,145 | -10% | -$4,608 | |
| 2026-01-27 | 2026-01-24 | ACET | Schor Chen | Pres, CEO, Dir | F - Tax | $8.44 | -1,755 | 6,820 | -20% | -$14.8K | |
| MI | 2025-10-10 | 2025-10-08 | ACET | ORBIMED ADVISORS LLC | 10% | P - Purchase | $1.00 | +5.00M | 4.49M | New | +$5.00M |
| D | 2025-06-13 | 2025-06-11 | ACET | Klickstein Lloyd | Dir | A - Grant | $0.00 | +5,900 | 108.6K | +6% | $0 |
| D | 2025-06-13 | 2025-06-11 | ACET | DUBIN STEVE | Dir | A - Grant | $0.00 | +5,900 | 22.7K | +35% | $0 |
| D | 2025-06-13 | 2025-06-11 | ACET | Peng Katie | Dir | A - Grant | $0.00 | +5,900 | 11.8K | +100% | $0 |
| D | 2025-06-13 | 2025-06-11 | ACET | Sinclair Andrew | Dir | A - Grant | $0.00 | +5,900 | 17.7K | +50% | $0 |
| D | 2025-06-13 | 2025-06-11 | ACET | Chodakewitz Jeffrey | Dir | A - Grant | $0.00 | +5,900 | 17.7K | +50% | $0 |
| 2025-01-28 | 2025-01-24 | ACET | Harvey Brian Nicholas | CFO | F - Tax | $0.92 | -8,752 | 91.0K | -9% | -$8,052 | |
| 2025-01-28 | 2025-01-24 | ACET | Aftab Blake | CSO | F - Tax | $0.92 | -6,270 | 56.2K | -10% | -$5,768 | |
| 2025-01-28 | 2025-01-24 | ACET | Schor Chen | Pres, CEO, Dir | F - Tax | $0.92 | -28.1K | 137.2K | -17% | -$25.9K | |
| 2025-01-28 | 2025-01-24 | ACET | Healey Don | CTO | F - Tax | $0.92 | -8,560 | 63.8K | -12% | -$7,875 | |
| D | 2024-06-07 | 2024-06-05 | ACET | Sinclair Andrew | Dir | A - Grant | $0.00 | +5,900 | 11.8K | +100% | $0 |
| D | 2024-06-07 | 2024-06-05 | ACET | Peng Katie | Dir | A - Grant | $0.00 | +5,900 | 5,900 | New | $0 |
| D | 2024-06-07 | 2024-06-05 | ACET | Jakobovits Aya | Dir | A - Grant | $0.00 | +5,900 | 11.8K | +100% | $0 |
| D | 2024-06-07 | 2024-06-05 | ACET | Chodakewitz Jeffrey | Dir | A - Grant | $0.00 | +5,900 | 11.8K | +100% | $0 |
| D | 2024-06-07 | 2024-06-05 | ACET | Kauffman Michael | Dir | S - Sale | $1.43 | -5,900 | 5,900 | -50% | -$8,437 |
| D | 2024-06-07 | 2024-06-05 | ACET | Kauffman Michael | Dir | A - Grant | $0.00 | +5,900 | 11.8K | +100% | $0 |
| D | 2024-06-07 | 2024-06-05 | ACET | DUBIN STEVE | Dir | A - Grant | $0.00 | +5,900 | 16.8K | +54% | $0 |
| D | 2024-06-07 | 2024-06-05 | ACET | GORDON CARL L | Dir, 10% | A - Grant | $0.00 | +5,900 | 11.8K | +100% | $0 |
| MI | 2024-01-26 | 2024-01-25 | ACET | GORDON CARL L | Dir, 10% | P - Purchase | $2.40 | +3.12M | 7.53M | +71% | +$7.50M |
| D | 2024-01-26 | 2024-01-24 | ACET | Harvey Brian Nicholas | CFO | A - Grant | $0.00 | +26.3K | 99.8K | +36% | $0 |
| D | 2024-01-26 | 2024-01-24 | ACET | Harvey Brian Nicholas | CFO | F - Tax | $2.40 | -4,320 | 73.5K | -6% | -$10.4K |
| D | 2024-01-26 | 2024-01-24 | ACET | Galimi Francesco | SVP, Chief Medical Off | A - Grant | $0.00 | +26.3K | 101.8K | +35% | $0 |
| D | 2024-01-26 | 2024-01-24 | ACET | Galimi Francesco | SVP, Chief Medical Off | F - Tax | $2.40 | -4,957 | 75.5K | -6% | -$11.9K |
| D | 2024-01-26 | 2024-01-24 | ACET | Schor Chen | Pres, CEO, Dir | A - Grant | $0.00 | +70.3K | 208.8K | +51% | $0 |
| D | 2024-01-26 | 2024-01-24 | ACET | Schor Chen | Pres, CEO, Dir | F - Tax | $2.40 | -15.3K | 138.5K | -10% | -$36.7K |
| D | 2024-01-26 | 2024-01-24 | ACET | Healey Don | CTO | A - Grant | $0.00 | +19.7K | 72.3K | +37% | $0 |
| D | 2024-01-26 | 2024-01-24 | ACET | Healey Don | CTO | F - Tax | $2.40 | -4,870 | 52.6K | -8% | -$11.7K |
| MI | 2024-01-26 | 2024-01-25 | ACET | OrbiMed Advisors Israel II Ltd | Dir, 10% | P - Purchase | $2.40 | +3.12M | 7.53M | +71% | +$7.50M |
| D | 2024-01-26 | 2024-01-24 | ACET | Aftab Blake | CSO | A - Grant | $0.00 | +19.7K | 62.5K | +46% | $0 |
| D | 2024-01-26 | 2024-01-24 | ACET | Aftab Blake | CSO | F - Tax | $2.40 | -3,565 | 42.8K | -8% | -$8,556 |
| 2023-10-16 | 2023-10-12 | ACET | Aftab Blake | CSO | F - Tax | $1.35 | -7,933 | 46.4K | -15% | -$10.7K | |
| 2023-10-03 | 2023-10-02 | ACET | Galimi Francesco | SVP, Chief Medical Off | F - Tax | $1.37 | -8,093 | 80.5K | -9% | -$11.1K | |
| 2023-10-03 | 2023-10-02 | ACET | Healey Don | CTO | F - Tax | $1.37 | -9,069 | 57.5K | -14% | -$12.4K | |
| 2023-10-03 | 2023-10-02 | ACET | Harvey Brian Nicholas | CFO | F - Tax | $1.37 | -7,096 | 77.8K | -8% | -$9,722 | |
| I | 2023-10-02 | 2023-09-28 | ACET | Schor Chen | Pres, CEO, Dir | S - Sale | $1.42 | -5,500 | 38.0K | -13% | -$7,810 |
| 2023-10-02 | 2023-09-28 | ACET | Schor Chen | Pres, CEO, Dir | P - Purchase | $1.42 | +5,500 | 182.5K | +3% | +$7,810 | |
| 2023-10-02 | 2023-09-29 | ACET | Schor Chen | Pres, CEO, Dir | S - Sale | $1.36 | -5,500 | 177.0K | -3% | -$7,480 | |
| 2023-10-02 | 2023-10-02 | ACET | Schor Chen | Pres, CEO, Dir | F - Tax | $1.37 | -23.2K | 153.8K | -13% | -$31.8K | |
| I | 2023-10-02 | 2023-10-02 | ACET | Schor Chen | Pres, CEO, Dir | P - Purchase | $1.33 | +5,500 | 43.5K | +14% | +$7,315 |
| 2023-06-30 | 2023-06-30 | ACET | DUBIN STEVE | Dir | P - Purchase | $2.40 | +5,000 | 10.9K | +85% | +$12.0K | |
| MI | 2023-06-29 | 2023-06-27 | ACET | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $2.09 | +875.0K | 1.03M | +572% | +$1.83M |
| MI | 2023-06-29 | 2023-06-27 | ACET | GORDON CARL L | Dir, 10% | P - Purchase | $2.09 | +875.0K | 1.03M | +572% | +$1.83M |
| D | 2023-06-02 | 2023-06-01 | ACET | Kauffman Michael | Dir | A - Grant | $0.00 | +5,900 | 5,900 | New | $0 |
| D | 2023-06-02 | 2023-06-01 | ACET | DUBIN STEVE | Dir | A - Grant | $0.00 | +5,900 | 5,900 | New | $0 |
| D | 2023-06-02 | 2023-06-01 | ACET | GORDON CARL L | Dir | A - Grant | $0.00 | +5,900 | 5,900 | New | $0 |
| D | 2023-06-02 | 2023-06-01 | ACET | Sinclair Andrew | Dir | A - Grant | $0.00 | +5,900 | 5,900 | New | $0 |
| D | 2023-06-02 | 2023-06-01 | ACET | Jakobovits Aya | Dir | A - Grant | $0.00 | +5,900 | 5,900 | New | $0 |
| D | 2023-06-02 | 2023-06-01 | ACET | Sanna Bastiano | Dir | A - Grant | $0.00 | +5,900 | 5,900 | New | $0 |
| D | 2023-06-02 | 2023-06-01 | ACET | Chodakewitz Jeffrey | Dir | A - Grant | $0.00 | +5,900 | 5,900 | New | $0 |
| 2023-02-17 | 2023-02-15 | ACET | Healey Don | CTO | S - Sale | $7.57 | -4,533 | 66.6K | -6% | -$34.3K | |
| 2023-02-14 | 2023-02-10 | ACET | Healey Don | CTO | S - Sale | $7.98 | -10.5K | 71.1K | -13% | -$83.5K | |
| D | 2023-01-26 | 2023-01-24 | ACET | Schor Chen | Pres, CEO, Dir | A - Grant | $0.00 | +85.5K | 177.0K | +93% | $0 |
| D | 2023-01-26 | 2023-01-24 | ACET | Aftab Blake | CSO | A - Grant | $0.00 | +26.1K | 54.3K | +93% | $0 |
| D | 2023-01-26 | 2023-01-24 | ACET | Galimi Francesco | SVP, Chief Medical Off | A - Grant | $0.00 | +26.1K | 88.6K | +42% | $0 |
| D | 2023-01-26 | 2023-01-24 | ACET | Harvey Brian Nicholas | CFO | A - Grant | $0.00 | +26.1K | 84.9K | +44% | $0 |
| D | 2023-01-26 | 2023-01-24 | ACET | Healey Don | CTO | A - Grant | $0.00 | +26.1K | 81.6K | +47% | $0 |
| I | 2022-11-15 | 2022-11-10 | ACET | Schor Chen | Pres, CEO, Dir | S - Sale | $20.06 | -30.0K | 53.4K | -36% | -$601.8K |
| 2022-11-15 | 2022-11-10 | ACET | Schor Chen | Pres, CEO, Dir | S - Sale | $21.03 | -9,955 | 91.5K | -10% | -$209.4K | |
| 2022-11-15 | 2022-11-10 | ACET | Aftab Blake | CSO | S - Sale | $21.00 | -6,967 | 28.2K | -20% | -$146.3K | |
| I | 2022-11-09 | 2022-11-07 | ACET | Schor Chen | Pres, CEO, Dir | S - Sale | $19.05 | -30.0K | 83.4K | -26% | -$571.5K |
| MI | 2022-11-04 | 2022-11-02+ | ACET | Schor Chen | Pres, CEO, Dir | S - Sale | $18.04 | -25.3K | 138.2K | -15% | -$456.6K |
| 2022-10-21 | 2022-10-19 | ACET | Aftab Blake | CSO | S - Sale | $16.27 | -8,067 | 35.2K | -19% | -$131.3K | |
| D | 2022-10-14 | 2022-10-13 | ACET | Aftab Blake | CSO | F - Tax | $15.92 | -7,933 | 43.2K | -16% | -$126.3K |
| D | 2022-10-14 | 2022-10-12 | ACET | Aftab Blake | CSO | M - OptEx | $7.38 | +3,388 | 52.8K | +7% | +$25.0K |
| D | 2022-10-14 | 2022-10-12 | ACET | Aftab Blake | CSO | S - Sale+OE | $15.40 | -1,646 | 51.2K | -3% | -$25.3K |
| 2022-10-04 | 2022-10-04 | ACET | Galimi Francesco | SVP, Chief Medical Off | F - Tax | $14.22 | -7,933 | 62.5K | -11% | -$112.8K | |
| 2022-10-04 | 2022-10-04 | ACET | Harvey Brian Nicholas | CFO | F - Tax | $14.22 | -7,096 | 58.8K | -11% | -$100.9K | |
| 2022-10-04 | 2022-10-04 | ACET | Schor Chen | Pres, CEO, Dir | F - Tax | $14.22 | -21.3K | 101.4K | -17% | -$302.7K | |
| 2022-10-04 | 2022-10-04 | ACET | Healey Don | CTO | F - Tax | $14.22 | -7,933 | 55.5K | -13% | -$112.8K | |
| I | 2022-09-16 | 2022-09-14 | ACET | Schor Chen | Pres, CEO, Dir | S - Sale | $18.00 | -952 | 138.7K | -0.7% | -$17.1K |
| MI | 2022-09-13 | 2022-09-09+ | ACET | Pres, CEO, Dir | S - Sale | $16.80 | -78.4K | 143.1K | -35% | -$1.32M | |
| 2022-08-08 | 2022-08-04 | ACET | Galimi Francesco | SVP, Chief Medical Off | F - Tax | $18.25 | -5,533 | 70.4K | -7% | -$101.0K | |
| 2022-08-08 | 2022-08-04 | ACET | Galimi Francesco | SVP, Chief Medical Off | A - Grant | $0.00 | +16.0K | 75.9K | +27% | $0 | |
| 2022-08-08 | 2022-08-04 | ACET | Harvey Brian Nicholas | CFO | A - Grant | $0.00 | +16.0K | 70.6K | +29% | $0 | |
| 2022-08-08 | 2022-08-04 | ACET | Harvey Brian Nicholas | CFO | F - Tax | $18.25 | -4,696 | 65.9K | -7% | -$85.7K | |
| 2022-08-08 | 2022-08-04 | ACET | Healey Don | CTO | F - Tax | $18.25 | -5,533 | 63.4K | -8% | -$101.0K | |
| 2022-08-08 | 2022-08-04 | ACET | Healey Don | CTO | A - Grant | $0.00 | +16.0K | 68.9K | +30% | $0 | |
| 2022-08-08 | 2022-08-04 | ACET | Schor Chen | Pres, CEO, Dir | F - Tax | $18.25 | -21.3K | 122.7K | -15% | -$388.5K | |
| 2022-08-08 | 2022-08-04 | ACET | Schor Chen | Pres, CEO, Dir | A - Grant | $0.00 | +48.0K | 144.0K | +50% | $0 | |
| I | 2022-08-08 | 2022-07-06 | ACET | Schor Chen | Pres, CEO, Dir | G - Gift | $0.00 | +53.4K | 143.3K | +59% | $0 |
| 2022-08-08 | 2022-07-06 | ACET | Schor Chen | Pres, CEO, Dir | G - Gift | $0.00 | -53.4K | 96.0K | -36% | $0 | |
| 2022-08-08 | 2022-08-04 | ACET | Aftab Blake | CSO | F - Tax | $18.25 | -5,533 | 49.4K | -10% | -$101.0K | |
| 2022-08-08 | 2022-08-04 | ACET | Aftab Blake | CSO | A - Grant | $0.00 | +16.0K | 55.0K | +41% | $0 | |
| 2022-08-05 | 2022-08-03 | ACET | Aftab Blake | CSO | S - Sale | $18.00 | -6,968 | 39.0K | -15% | -$125.4K | |
| 2022-08-03 | 2022-08-01 | ACET | Aftab Blake | CSO | S - Sale | $16.64 | -6,968 | 45.9K | -13% | -$115.9K | |
| 2022-07-07 | 2022-07-05 | ACET | Aftab Blake | CSO | S - Sale | $14.50 | -1,363 | 52.9K | -3% | -$19.8K | |
| DM | 2022-04-05 | 2022-04-01+ | ACET | Galimi Francesco | SVP, Chief Medical Off | S - Sale+OE | $21.00 | -15.6K | 59.9K | -21% | -$327.6K |
| DM | 2022-04-05 | 2022-04-01+ | ACET | Galimi Francesco | SVP, Chief Medical Off | M - OptEx | $10.03 | +15.6K | 66.0K | +31% | +$156.5K |
| MI | 2022-03-11 | 2022-03-09 | ACET | Jakobovits Aya | Dir | S - Sale | $14.00 | -4,000 | 356.3K | -1% | -$56.0K |
| MI | 2022-02-17 | 2022-02-16 | ACET | Jakobovits Aya | Dir | S - Sale | $14.83 | -4,000 | 358.3K | -1% | -$59.3K |
| 2022-02-16 | 2022-02-14 | ACET | Schor Chen | Pres, CEO, Dir | F - Tax | $14.27 | -21.3K | 149.4K | -12% | -$303.8K | |
| 2022-02-16 | 2022-02-14 | ACET | Schor Chen | Pres, CEO, Dir | A - Grant | $0.00 | +48.0K | 170.7K | +39% | $0 | |
| 2022-02-16 | 2022-02-14 | ACET | Healey Don | CTO | F - Tax | $14.27 | -5,533 | 52.9K | -9% | -$79.0K |
Purchase Sale Sale after option exercise All abbreviations